Retraction
LncRNA EWSAT1 Promotes Colorectal Cancer Progression Through Sponging miR-326 to Modulate FBXL20 Expression
Paper Information
Record ID:
48523
Journal:
Publication Date:
January 13, 2021
Retraction Date:
October 20, 2023
(2.1 years years ago)
Subjects:
Institutions:
- Imaging Department, Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China
- Forensic Clinical Teaching and Research Office, Guizhou Medical University, Guiyang, People’s Republic of China
- Surgery, Guizhou Medical University, Guiyang, People’s Republic of China
- Department of Pathology, Guiyang Maternal and Child Health Hospital, Guiyang, People’s Republic of China
- General Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China
- Department of Traditional Chinese Medicine, Guizhou Provincial People’s Hospital, Guiyang, People’s Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.2147/OTT.S445558Additional Notes:
see also: https://pubpeer.com/publications/89EE40D367E4C027D551A46E4042C3
Citations (17)
17
Total Citations3
Post-Retraction(17.6%)
14
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
3
Within 1 year
0
After 2+ years
159
Days since retraction (latest)
LncRNA Inhibits the Viability of Triple-Negative Breast Cancer (TNBC) by Targeting the miR-330-5p/BCL2L2 Axis
Haihan Ye, Xiaowei Fan, Enyu Yang et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Mar 2024
159 days after retraction
Non-coding RNAs involved in fibroblast-like synoviocyte functioning in arthritis rheumatoid: From pathogenesis to therapy
Yuwei Peng, Meng Zhang, Jiangkang Hu
Cytokine
Published: Nov 2023
7 citations
7 citations
21 days after retraction
Circulating long non-coding RNA EWSAT1 acts as a liquid biopsy marker for esophageal squamous cell carcinoma: A pilot study
Vivek Uttam, Manjit Kaur Rana, Uttam Sharma et al. (5 authors)
Non-coding RNA Research
Open Access
Published: Oct 2023
9 citations
9 citations
8 days after retraction
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
Fang Zhang, Rixin Zhang, Jinbao Zong et al. (13 authors)
Frontiers in Immunology
Open Access
Published: Oct 2023
1 citation
1 citation
1 days before retraction
Research progress of miRNA-326 in malignant tumors
Lin Feng
Unknown Journal
Open Access
Published: Mar 2023
1 citation
1 citation
218 days before retraction
MiR-326 regulates cell proliferation and apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis
Wang Yiou, Zhihong Wang, Zhu Shibai et al. (5 authors)
Human Cell
Published: Feb 2023
8 citations
8 citations
255 days before retraction
Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
Sara Hajibabaei, Fattah Sotoodehnejadnematalahi, Nahid Nafissi et al. (5 authors)
Scientific Reports
Open Access
Published: Jan 2023
18 citations
18 citations
275 days before retraction
A novel cuproptosis-related LncRNA signature predicts prognosis inpatients with esophageal carcinoma
Shang Peng, LI Hai-peng, Jingting Min et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Jan 2023
283 days before retraction
SP1-induced PROX1-AS1 contributes to tumor progression by regulating miR-326/FBXL20 axis in colorectal cancer
Jing Liu, Wei Zhan, Gang Chen et al. (6 authors)
Cellular Signalling
Published: Oct 2022
8 citations
8 citations
355 days before retraction
Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells
Zhifeng Wang, Jingmei Liu, Tao Yang et al. (6 authors)
Molecular and Cellular Biochemistry
Published: Oct 2022
12 citations
12 citations
374 days before retraction
Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
Sara Hajibabaei, Fattah Sotoodehnejadnematalahi, Nahid Nafissi et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Sep 2022
401 days before retraction
Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis
Dave N.T. Aryee, Valerie Fock, Utkarsh Kapoor et al. (5 authors)
Cells
Open Access
Published: Apr 2022
7 citations
7 citations
560 days before retraction
Clinicopathological and prognostic significance of long non-coding RNA EWSAT1 in human cancers: A review and meta analysis
Jian Wen, Haima Li, Dongdong Li et al. (4 authors)
PLoS ONE
Open Access
Published: Mar 2022
4 citations
4 citations
585 days before retraction
Long non-coding RNA AC087388.1 as a novel biomarker in colorectal cancer
Arash Poursheikhani, Mohammad Reza Abbaszadegan, Mohammad Amin Kerachian
BMC Cancer
Open Access
Published: Feb 2022
5 citations
5 citations
606 days before retraction
The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer
Chen Liu, Yuhan Huang, Yaoyuan Cui et al. (28 authors)
Frontiers in Immunology
Open Access
Published: Jan 2022
18 citations
18 citations
644 days before retraction
The Landscape of Regulatory Noncoding RNAs in Ewing’s Sarcoma
Connor Barrett, Anuj Budhiraja, Vijay Parashar et al. (4 authors)
Biomedicines
Open Access
Published: Jul 2021
10 citations
10 citations
811 days before retraction
Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes
Carolina Mathias, João C. D. Muzzi, Bruna Borba Antunes et al. (6 authors)
Frontiers in Oncology
Open Access
Published: May 2021
40 citations
40 citations
872 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025